TEVA vs. IVV
Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and iShares Core S&P 500 ETF (IVV).
IVV is a passively managed fund by iShares that tracks the performance of the S&P 500 Index. It was launched on May 15, 2000.
Performance
TEVA vs. IVV - Performance Comparison
Loading graphics...
TEVA vs. IVV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | -3.08% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
IVV iShares Core S&P 500 ETF | -3.67% | 17.85% | 24.93% | 26.31% | -18.16% | 28.76% | 18.40% | 31.07% | -4.49% | 21.75% |
Returns By Period
In the year-to-date period, TEVA achieves a -3.08% return, which is significantly higher than IVV's -3.67% return. Over the past 10 years, TEVA has underperformed IVV with an annualized return of -5.21%, while IVV has yielded a comparatively higher 14.11% annualized return.
TEVA
- 1D
- 0.43%
- 1M
- -10.42%
- YTD
- -3.08%
- 6M
- 50.80%
- 1Y
- 97.84%
- 3Y*
- 50.64%
- 5Y*
- 21.38%
- 10Y*
- -5.21%
IVV
- 1D
- 0.74%
- 1M
- -4.30%
- YTD
- -3.67%
- 6M
- -1.44%
- 1Y
- 18.17%
- 3Y*
- 18.58%
- 5Y*
- 11.92%
- 10Y*
- 14.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. IVV — Risk / Return Rank
TEVA
IVV
TEVA vs. IVV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TEVA | IVV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.33 | 1.00 | +1.33 |
Sortino ratioReturn per unit of downside risk | 3.11 | 1.52 | +1.59 |
Omega ratioGain probability vs. loss probability | 1.42 | 1.23 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 4.44 | 1.54 | +2.90 |
Martin ratioReturn relative to average drawdown | 12.93 | 7.28 | +5.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| TEVA | IVV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.33 | 1.00 | +1.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.50 | 0.71 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.11 | 0.78 | -0.90 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.42 | -0.12 |
Correlation
The correlation between TEVA and IVV is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
TEVA vs. IVV - Dividend Comparison
TEVA has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.22%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
IVV iShares Core S&P 500 ETF | 1.22% | 1.17% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.85% | 2.21% | 1.75% | 2.01% | 2.27% |
Drawdowns
TEVA vs. IVV - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for TEVA and IVV.
Loading graphics...
Drawdown Indicators
| TEVA | IVV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -55.25% | -35.64% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -12.06% | -9.73% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -24.53% | -19.17% |
Max Drawdown (10Y)Largest decline over 10 years | -88.71% | -33.90% | -54.81% |
Current DrawdownCurrent decline from peak | -55.29% | -5.57% | -49.72% |
Average DrawdownAverage peak-to-trough decline | -31.90% | -10.84% | -21.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.49% | 2.55% | +4.94% |
Volatility
TEVA vs. IVV - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 11.82% compared to iShares Core S&P 500 ETF (IVV) at 5.34%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| TEVA | IVV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.82% | 5.34% | +6.48% |
Volatility (6M)Calculated over the trailing 6-month period | 27.30% | 9.47% | +17.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.20% | 18.31% | +23.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.76% | 16.89% | +25.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.20% | 18.03% | +29.17% |